9.42 (-%)
As of Oct 30, 2024
Source:
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients lives byOvercomingResistanceInCancer. Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 388-5600 |
Industry | manufacturing |
CEO | Jacob M. Chacko |
Website | www.oricpharma.com |